Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN638430 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN638430, RRID:AB_11209946
- Product name
- anti-CD14 Molecule (CD14) antibody
- Antibody type
- Monoclonal
- Description
- Purified by protein A
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- MEM-18
- Vial size
- 0.1 mg
- Storage
- Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label.
- Handling
- Do not freeze.
Submitted references Hepatic progenitor cells from adult human livers for cell transplantation.
Soluble CD14: role in atopic disease and recurrent infections, including otitis media.
CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts.
Single-molecule microscopy reveals heterogeneous dynamics of lipid raft components upon TCR engagement.
Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation.
The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain.
CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL.
CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited.
Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.
Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14.
Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen.
Weiss TS, Lichtenauer M, Kirchner S, Stock P, Aurich H, Christ B, Brockhoff G, Kunz-Schughart LA, Jauch KW, Schlitt HJ, Thasler WE
Gut 2008 Aug;57(8):1129-38
Gut 2008 Aug;57(8):1129-38
Soluble CD14: role in atopic disease and recurrent infections, including otitis media.
Lødrup Carlsen KC, Granum B
Current allergy and asthma reports 2007 Nov;7(6):436-43
Current allergy and asthma reports 2007 Nov;7(6):436-43
CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts.
Angel CE, Lala A, Chen CJ, Edgar SG, Ostrovsky LL, Dunbar PR
International immunology 2007 Nov;19(11):1271-9
International immunology 2007 Nov;19(11):1271-9
Single-molecule microscopy reveals heterogeneous dynamics of lipid raft components upon TCR engagement.
Drbal K, Moertelmaier M, Holzhauser C, Muhammad A, Fuertbauer E, Howorka S, Hinterberger M, Stockinger H, Schütz GJ
International immunology 2007 May;19(5):675-84
International immunology 2007 May;19(5):675-84
Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation.
Asai Y, Makimura Y, Kawabata A, Ogawa T
Journal of immunology (Baltimore, Md. : 1950) 2007 Dec 1;179(11):7674-83
Journal of immunology (Baltimore, Md. : 1950) 2007 Dec 1;179(11):7674-83
The CD14 region spanning amino acids 57-64 is critical for interaction with the extracellular Toll-like receptor 2 domain.
Iwaki D, Nishitani C, Mitsuzawa H, Hyakushima N, Sano H, Kuroki Y
Biochemical and biophysical research communications 2005 Mar 4;328(1):173-6
Biochemical and biophysical research communications 2005 Mar 4;328(1):173-6
CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.
Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W
The Journal of clinical endocrinology and metabolism 2003 Apr;88(4):1780-4
The Journal of clinical endocrinology and metabolism 2003 Apr;88(4):1780-4
Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression.
Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher M, Heesemann J
The Journal of experimental medicine 2002 Oct 21;196(8):1017-24
The Journal of experimental medicine 2002 Oct 21;196(8):1017-24
Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL.
Stöckl J, Majdic O, Fischer G, Maurer D, Knapp W
Journal of immunology (Baltimore, Md. : 1950) 2001 Sep 1;167(5):2724-33
Journal of immunology (Baltimore, Md. : 1950) 2001 Sep 1;167(5):2724-33
CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited.
Funda DP, Tucková L, Farré MA, Iwase T, Moro I, Tlaskalová-Hogenová H
Infection and immunity 2001 Jun;69(6):3772-81
Infection and immunity 2001 Jun;69(6):3772-81
Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding.
Juan TS, Hailman E, Kelley MJ, Wright SD, Lichenstein HS
The Journal of biological chemistry 1995 Jul 21;270(29):17237-42
The Journal of biological chemistry 1995 Jul 21;270(29):17237-42
Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14.
Bazil V, Baudys M, Hilgert I, Stefanová I, Low MG, Zbrozek J, Horejsí V
Molecular immunology 1989 Jul;26(7):657-62
Molecular immunology 1989 Jul;26(7):657-62
Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen.
Bazil V, Horejsí V, Baudys M, Kristofová H, Strominger JL, Kostka W, Hilgert I
European journal of immunology 1986 Dec;16(12):1583-9
European journal of immunology 1986 Dec;16(12):1583-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS
